Internal Medicine, Nephrology · Beaufort, SC
NPI
1376785394
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
16 Kemmerlin Ln Ste A
Beaufort, SC, 29907
Phone (843) 524-2002
Groups this clinician bills Medicare through
Medicare paid, 2024
$260K
2,931 services
Medicare patients, 2024
861
Average age 77
Drug cost, 2024
$1.8M
3,815 prescriptions
Company payments, 2025
$267K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica M Coleman was code 99214 (office e&m - established), 644 times for 448 patients. In total Jessica M Coleman billed 2,931 services in 21 codes, and Medicare paid $260K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 644 | 448 | $89.40 | $58K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 554 | 338 | $12.84 | $7,114 |
| 99232 Hospital E&M - Subsequent | Facility | 514 | 203 | $61.67 | $32K |
| 99215 Office E&M - Established | Office | 296 | 233 | $128.94 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 252 | 112 | $94.61 | $24K |
| 99223 Hospital E&M - Initial | Facility | 210 | 176 | $133.85 | $28K |
| 90966 ESRD Related Services (not dialysis) | Office | 143 | 21 | $235.48 | $34K |
| 90935 Hemodialysis | Facility | 122 | 40 | $56.27 | $6,865 |
| 90960 ESRD Related Services (not dialysis) | Office | 74 | 27 | $284.11 | $21K |
| 99222 Hospital E&M - Initial | Facility | 20 | 19 | $94.31 | $1,886 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 16 | 14 | $50.76 | $812 |
By year: 2022 $437K for 4,010 services; 2023 $353K for 3,191 services; 2024 $260K for 2,931 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica M Coleman prescribed most often to Medicare patients was Losartan Potassium, with 290 prescriptions and refills. In total Jessica M Coleman wrote 3,815 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 290 | 794 | 104 | $2,850 |
| Nifedipine Er Nifedipine | 278 | 640 | 86 | $9,090 |
| Allopurinol Generic | 251 | 689 | 86 | $2,082 |
| Furosemide Generic | 215 | 585 | 80 | $1,404 |
| Amlodipine Besylate Generic | 208 | 606 | 81 | $1,223 |
| Carvedilol Generic | 194 | 493 | 61 | $1,794 |
| Kerendia Finerenone | 186 | 327 | 39 | $212K |
| Farxiga Dapagliflozin Propanediol | 186 | 390 | 52 | $212K |
| Lisinopril Generic | 154 | 443 | 50 | $1,237 |
| Bumetanide Generic | 118 | 232 | 43 | $5,376 |
| Calcitriol Generic | 78 | 215 | 28 | $2,126 |
| Velphoro Sucroferric Oxyhydroxide | 77 | 91 | 22 | $218K |
| Lokelma Sodium Zirconium Cyclosilicate | 71 | 128 | 24 | $80K |
| Xphozah Tenapanor Hcl | 66 | 108 | 15 | $320K |
| Ciprofloxacin Hcl Generic | 65 | 65 | 60 | $605 |
Brand drugs: 814 claims; generic drugs: 3,001 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica M Coleman $267K ($267K in general payments such as food, travel and fees) from 23 companies. The largest payer was Travere Therapeutics, Inc. with $95K.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 181 | $95K |
| Akebia Therapeutics Inc AKBA | 91 | $45K |
| Novartis Pharmaceuticals Corporation NVS | 33 | $22K |
| ANI Pharmaceuticals, Inc. ANIP | 37 | $21K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 38 | $21K |
| Ardelyx, Inc. ARDX | 19 | $19K |
| Amgen Inc. AMGN | 41 | $18K |
| Calliditas Therapeutics US Inc. | 27 | $15K |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $3,813 |
| Fresenius USA Marketing, Inc. | 4 | $2,808 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.